We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel Magnetic Resonance System Rapidly Determines Malaria Parasite Load

By LabMedica International staff writers
Posted on 07 Sep 2014
A novel diagnostic technique based on magnetic resonance relaxometry (MRR) was able to rapidly and accurately determine severity of malaria infection without using chemical or immunolabeling.

When malaria parasites grow within host red blood cells they metabolize large amounts of hemoglobin and convert it into hemozoin crystallites. More...
These hemozoin particles possess relatively large paramagnetic susceptibility, which induces substantial changes in the transverse relaxation rate of proton nuclear magnetic resonance of infected red blood cells. The relaxation rate is a measure of how the nuclear magnetic resonance of hydrogen atoms is affected by the proximity of other magnetic particles – in this case hemozoin.

Researchers at the Massachusetts Institute of Technology (Cambridge, USA) and colleagues at Nanyang Technical University (Singapore) prepared a benchtop size MRI instrument around a 0.5-Tesla magnet, which was less expensive and powerful than the 2- or 3-Tesla magnets typically required for MRI diagnostic imaging. They used this instrument to determine numbers of Plasmodium falicparum parasites growing in vitro and Plasmodium berghei parasites taken from infected mice. Blood samples of 10 microliters or less were concentrated by centrifugation and then analyzed without further preparation or labeling.

Results revealed that a parasitemia level of fewer than ten parasites per microliter in a volume below 10 microliters of whole blood was detected in a few minutes for cultured Plasmodium falciparum parasites and in vivo with Plasmodium berghei-infected mice.

"Hemozoin crystals are produced in all four stages of malaria infection, including the earliest stages, and are generated by all known species of the Plasmodium parasite," said senior author Dr. Jongyoon Han, professor of electrical engineering and biological engineering at the Massachusetts Institute of Technology. "Also, the amount of hemozoin can reveal how severe the infection is, or whether it is responding to treatment. There are a lot of scenarios where you want to see the number, rather than a yes or no answer. There is real potential to make this into a field-deployable system, especially since you do not need any kind of labels or dye. It is based on a naturally occurring biomarker that does not require any biochemical processing of samples."

A paper describing the technique was published in the August 31, 2014, online edition of the journal Nature Medicine.

Related Links:

Massachusetts Institute of Technology
Nanyang Technical University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.